| 1 | 1 | | I |
|---|
| 2 | 2 | | 119THCONGRESS |
|---|
| 3 | 3 | | 1 |
|---|
| 4 | 4 | | STSESSION H. R. 89 |
|---|
| 5 | 5 | | To repeal the authority of the Food and Drug Administration to require |
|---|
| 6 | 6 | | that drugs be dispensed only upon prescription, and for other purposes. |
|---|
| 7 | 7 | | IN THE HOUSE OF REPRESENTATIVES |
|---|
| 8 | 8 | | JANUARY3, 2025 |
|---|
| 9 | 9 | | Mr. B |
|---|
| 10 | 10 | | IGGSof Arizona introduced the following bill; which was referred to the |
|---|
| 11 | 11 | | Committee on Energy and Commerce |
|---|
| 12 | 12 | | A BILL |
|---|
| 13 | 13 | | To repeal the authority of the Food and Drug Administration |
|---|
| 14 | 14 | | to require that drugs be dispensed only upon prescrip- |
|---|
| 15 | 15 | | tion, and for other purposes. |
|---|
| 16 | 16 | | Be it enacted by the Senate and House of Representa-1 |
|---|
| 17 | 17 | | tives of the United States of America in Congress assembled, 2 |
|---|
| 18 | 18 | | SECTION 1. SHORT TITLE. 3 |
|---|
| 19 | 19 | | This Act may be cited as the ‘‘Prescription Freedom 4 |
|---|
| 20 | 20 | | Act of 2025’’. 5 |
|---|
| 21 | 21 | | SEC. 2. REPEAL OF FDA AUTHORITY TO REQUIRE PRE-6 |
|---|
| 22 | 22 | | SCRIPTIONS. 7 |
|---|
| 23 | 23 | | (a) R |
|---|
| 24 | 24 | | EPEAL.—Effective as of the date that is 6 8 |
|---|
| 25 | 25 | | months after the date of enactment of this Act, subsection 9 |
|---|
| 26 | 26 | | VerDate Sep 11 2014 02:34 Jan 29, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H89.IH H89 |
|---|
| 27 | 27 | | ssavage on LAPJG3WLY3PROD with BILLS 2 |
|---|
| 28 | 28 | | •HR 89 IH |
|---|
| 29 | 29 | | (b) of section 503 of the Federal Food, Drug, and Cos-1 |
|---|
| 30 | 30 | | metic Act (21 U.S.C. 353) is repealed. 2 |
|---|
| 31 | 31 | | (b) R |
|---|
| 32 | 32 | | EFERENCES.—Beginning on the effective date 3 |
|---|
| 33 | 33 | | described in subsection (a), any reference in a Federal 4 |
|---|
| 34 | 34 | | statute, regulation, or guidance— 5 |
|---|
| 35 | 35 | | (1) to prescribing, a prescription, a prescription 6 |
|---|
| 36 | 36 | | drug, or a drug subject to section 503(b) of the Fed-7 |
|---|
| 37 | 37 | | eral Food, Drug, and Cosmetic Act is deemed to be 8 |
|---|
| 38 | 38 | | a reference to prescribing, a prescription, or a pre-9 |
|---|
| 39 | 39 | | scription drug, respectively, under applicable State 10 |
|---|
| 40 | 40 | | law; and 11 |
|---|
| 41 | 41 | | (2) to any requirement or provision of section 12 |
|---|
| 42 | 42 | | 503(b) of the Federal Food, Drug, and Cosmetic Act 13 |
|---|
| 43 | 43 | | is deemed to be a reference to the corresponding re-14 |
|---|
| 44 | 44 | | quirement or provision, if any, in applicable State 15 |
|---|
| 45 | 45 | | law, as determined by the Federal official or officials 16 |
|---|
| 46 | 46 | | responsible for administering the respective Federal 17 |
|---|
| 47 | 47 | | statute, regulation, or guidance. 18 |
|---|
| 48 | 48 | | (c) E |
|---|
| 49 | 49 | | XCEPTION.—Notwithstanding subsections (a) 19 |
|---|
| 50 | 50 | | and (b), the Secretary of Health and Human Services may 20 |
|---|
| 51 | 51 | | continue to exercise the authority vested by subsection (b) 21 |
|---|
| 52 | 52 | | of section 503 of the Federal Food, Drug, and Cosmetic 22 |
|---|
| 53 | 53 | | Act (21 U.S.C. 353), as in effect on the day before the 23 |
|---|
| 54 | 54 | | effective date described in subsection (a), with respect to 24 |
|---|
| 55 | 55 | | VerDate Sep 11 2014 02:34 Jan 29, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H89.IH H89 |
|---|
| 56 | 56 | | ssavage on LAPJG3WLY3PROD with BILLS 3 |
|---|
| 57 | 57 | | •HR 89 IH |
|---|
| 58 | 58 | | any drug that is intended for use in terminating a preg-1 |
|---|
| 59 | 59 | | nancy. 2 |
|---|
| 60 | 60 | | Æ |
|---|
| 61 | 61 | | VerDate Sep 11 2014 02:34 Jan 29, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H89.IH H89 |
|---|
| 62 | 62 | | ssavage on LAPJG3WLY3PROD with BILLS |
|---|